Table 10 Anticancer potential of pyrazolo[1,5-a]pyrimidine conjugate (29–30)
From: Estrogen alpha receptor antagonists for the treatment of breast cancer: a review
Compound No. | IC50 = µM |
|---|---|
MCF-7 Cancer cell line | |
29 | 1.79 |
30 | 2.16 |
Doxorubicin | 0.473 µM |